Status:
COMPLETED
Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborating Sponsors:
Pfizer
Conditions:
Gastrointestinal Stromal Tumors
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective medical record abstraction to evaluate the patterns of care for Gastrointestinal stromal tumors (GIST) in the community setting. Patient demographics and characteristics along ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients diagnosed with GIST based on ICD-9 code from January 2005 to present will be eligible. This will include current active patients as well as patients who have expired and have medical chart available.
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00877045
Start Date
January 1 2008
End Date
February 1 2009
Last Update
August 4 2010
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Cancer Specialists
Fort Myers, Florida, United States, 33901
2
Georgia Cancer Specialists
Atlanta, Georgia, United States, 30341
3
Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States, 37404
4
Tennessee Oncology, PLLC
Nashville, Tennessee, United States, 37023